Breaking News3 years ago
Breast Cancer Drug Benefits Broader Group of Patients, Trial Shows
[ad_1] Newswise — DALLAS – Oct. 28, 2022 – A drug approved to treat breast cancer patients with mutations in the BRCA1 or BRCA2 genes may also benefit people who...